Altria Holds Investor Day; Revises 2013 Full-Year Reported EPS Guidance and Reaffirms 2013 Full-Year Adjusted EPS Guidance
Altria Group, Inc. (Altria) (NYSE: MO) is holding an investor day
conference in New York City today. During today’s meeting, Marty
Barrington, Altria’s Chairman and Chief Executive Officer, and other
members of the Altria management team will discuss why Altria is a
compelling investment and review plans to continue creating value for
shareholders.
The presentation will focus on the strengths that support Altria’s
ability to achieve its long-term business objectives. These include:
-
The most diverse business model among its U.S. tobacco peers;
-
Leading premium tobacco brands;
-
A systematic approach to innovation, including new products;
-
Well-developed capabilities to address legislation, regulation and
litigation challenges;
-
Proven cost management; and
-
A strong balance sheet that supports excellent cash returns to
shareholders, primarily through dividends.
Today’s presentation will also include an update on Altria’s tobacco
companies’ plans for developing a range of innovative new products to
meet the evolving preferences of adult tobacco consumers. Altria’s
subsidiary, Nu Mark LLC (Nu Mark), plans to enter the e-vapor category
with the introduction of MarkTen e-cigarettes into a lead market
in Indiana this August. Nu Mark also plans to expand distribution of Verve®
discs to additional stores in Virginia in the second half of this year.
The presentation is being webcast live at altria.com in a listen-only
mode, beginning at approximately 9:00 a.m., Eastern Time. A copy of the
remarks and business presentation (including reconciliations of GAAP
financial measures to non-GAAP financial measures) and a replay of the
audio webcast of the remarks will be available at altria.com.
2013 Full-Year Guidance
Altria has revised its guidance for 2013 full-year reported diluted EPS
from a range of $2.49 to $2.55 to a range of $2.50 to $2.56 to reflect
the impact of an additional $36 million credit to be applied against
Philip Morris USA Inc.’s (PM USA) Master Settlement Agreement payment
obligations as a result of two more states joining the previously
disclosed settlement with certain states of the non-participating
manufacturer (NPM) adjustment disputes for 2003-2012. The forecast also
reflects estimated SABMiller plc (SABMiller) special items.
Altria reaffirms its guidance for 2013 full-year adjusted diluted EPS,
which excludes special items shown in the table below, to be in the
range of $2.35 to $2.41, representing a growth rate of 6% to 9% from an
adjusted diluted EPS base of $2.21 in 2012.
The factors described in the Forward-Looking and Cautionary Statements
section of this release represent continuing risks to this forecast.
Reconciliations of full-year adjusted to reported diluted EPS are shown
in the table below.
Altria’s Full-Year Earnings Per Share Guidance Excluding Special
Items
|
|
|
|
|
|
|
Full Year
|
|
|
|
|
|
|
2013 Guidance
|
|
|
2012
|
|
|
Change
|
Reported diluted EPS
|
|
|
|
|
|
$
|
|
2.50
|
|
|
to
|
|
|
$
|
|
2.56
|
|
|
|
$
|
|
2.06
|
|
|
|
21
|
%
|
|
|
to
|
|
|
24%
|
Loss on early extinguishment of debt
|
|
|
|
|
|
|
|
|
|
|
—
|
|
|
|
0.28
|
|
|
|
|
|
|
|
|
|
|
NPM Adjustment
|
|
|
|
|
|
|
|
|
|
|
(0.16
|
)
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
Asset impairment, exit and implementation costs
|
|
|
|
|
|
|
|
|
|
|
—
|
|
|
|
0.01
|
|
|
|
|
|
|
|
|
|
|
SABMiller special items
|
|
|
|
|
|
|
|
|
|
|
0.01
|
|
|
|
(0.08
|
)
|
|
|
|
|
|
|
|
|
|
PMCC leveraged lease benefit
|
|
|
|
|
|
|
|
|
|
|
—
|
|
|
|
(0.03
|
)
|
|
|
|
|
|
|
|
|
|
Tax items*
|
|
|
|
|
|
|
|
|
|
|
—
|
|
|
|
(0.03
|
)
|
|
|
|
|
|
|
|
|
|
Adjusted diluted EPS
|
|
|
|
|
|
$
|
|
2.35
|
|
|
to
|
|
|
$
|
|
2.41
|
|
|
|
$
|
|
2.21
|
|
|
|
6%
|
|
|
to
|
|
|
9%
|
* Excludes the tax impact of the Philip Morris Capital Corporation
(PMCC) leveraged lease benefit.
Altria’s Profile
Altria directly or indirectly owns 100% of each of PM USA, U.S.
Smokeless Tobacco Company LLC (USSTC), John Middleton Co. (Middleton),
Nu Mark, Ste. Michelle Wine Estates Ltd. (Ste. Michelle) and PMCC.
Altria holds a continuing economic and voting interest in SABMiller.
The brand portfolios of Altria’s tobacco operating companies include
such well-known names as Marlboro®, Black &
Mild®, Copenhagen® and
Skoal®. Ste. Michelle produces and markets
premium wines sold under various labels, including Chateau Ste.
Michelle®, Columbia Crest®,
14 Hands® and Stag’s Leap Wine Cellars®,
and it imports and markets Antinori®, Champagne
Nicolas Feuillatte™ and Villa Maria Estate™
products in the United States. Trademarks and service marks related to
Altria referenced in this release are the property of Altria or its
subsidiaries or are used with permission. More information about Altria
is available at altria.com.
Forward-Looking and Cautionary Statements
This press release contains projections of future results and other
forward-looking statements that involve a number of risks and
uncertainties and are made pursuant to the Safe Harbor Provisions of the
Private Securities Litigation Reform Act of 1995.
Important factors that may cause actual results and outcomes to differ
materially from those contained in the projections and forward-looking
statements included in this press release are described in Altria’s
publicly filed reports, including its Annual Report on Form 10-K for the
year ended December 31, 2012 and its Quarterly Report on Form 10-Q for
the period ended March 31, 2013.
These factors include the following: Altria’s tobacco businesses
(including PM USA, USSTC, Middleton and Nu Mark) being subject to
significant competition; changes in adult consumer preferences and
demand for their products; fluctuations in raw material availability,
quality and cost; reliance on key facilities and suppliers; reliance on
critical information systems, many of which are managed by third-party
service providers; fluctuations in levels of customer inventories; the
effects of global, national and local economic and market conditions;
changes to income tax laws; federal, state and local legislative
activity, including actual and potential federal and state excise tax
increases; increasing marketing and regulatory restrictions; the effects
of price increases related to excise tax increases and concluded tobacco
litigation settlements on trade inventories, consumption rates and
consumer preferences within price segments; health concerns relating to
the use of tobacco products and exposure to environmental tobacco smoke;
privately imposed smoking restrictions; and, from time to time,
governmental investigations.
Furthermore, the results of Altria’s tobacco businesses are dependent
upon their continued ability to promote brand equity successfully; to
anticipate and respond to evolving adult consumer preferences; to
develop successful new product technologies and markets within and
potentially outside the United States; to broaden brand portfolios in
order to compete effectively; and to improve productivity.
Altria and its tobacco businesses are also subject to federal, state and
local government regulation, including broad-based regulation of PM USA
and USSTC by the U.S. Food and Drug Administration. Altria and its
subsidiaries continue to be subject to litigation, including risks
associated with adverse jury and judicial determinations, courts
reaching conclusions at variance with the companies’ understanding of
applicable law, bonding requirements in the limited number of
jurisdictions that do not limit the dollar amount of appeal bonds and
certain challenges to bond cap statutes.
Altria cautions that the foregoing list of important factors is not
complete and does not undertake to update any forward-looking statements
that it may make except as required by applicable law. All subsequent
written and oral forward-looking statements attributable to Altria or
any person acting on its behalf are expressly qualified in their
entirety by the cautionary statements referenced above.
<div class="copyright">
Copyright Business Wire 2013
</div>